According to our (Global Info Research) latest study, the global Automated Cell Counter with Viability Analysis market size was valued at US$ 440 million in 2025 and is forecast to a readjusted size of US$ 829 million by 2032 with a CAGR of 9.6% during review period.
In 2025, global Automated Cell Counter with Viability Analysis production reached approximately 53.50 k units, with an average global market price of around USD8,000 per unit. The gross profit margin of major manufacturers ranges from 45.00% to 57.00%. In 2025, global production capacity reached approximately 70.39 k units.
An Automated Cell Counter with Viability Analysis is a laboratory instrument designed to rapidly determine cell concentration and cell viability using optical imaging, fluorescence or electrical sensing technologies. It provides accurate and reproducible counting while minimizing manual error and supports suspension cell analysis in research, biopharmaceutical production and clinical laboratories. The product is widely used for cell culture monitoring, quality control and sample preparation but does not replace flow cytometry or advanced cell imaging systems.
The upstream industry includes optical sensors, CMOS cameras, microfluidic chips, electronic components, reagents, disposable counting slides and software. Midstream covers instrument development, assembly, calibration, software integration and quality assurance. Downstream demand mainly comes from pharmaceutical companies, biotechnology firms, hospitals, academic laboratories, cell therapy facilities and contract research organizations. Increasing investment in biologics, regenerative medicine and laboratory automation continues to support market growth.
This report is a detailed and comprehensive analysis for global Automated Cell Counter with Viability Analysis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Automated Cell Counter with Viability Analysis market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Cell Counter with Viability Analysis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Cell Counter with Viability Analysis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Automated Cell Counter with Viability Analysis market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Automated Cell Counter with Viability Analysis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Automated Cell Counter with Viability Analysis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Beckman Coulter Life Sciences, Bio-Rad Laboratories, Inc., Logos Biosystems, Inc., ChemoMetec A/S, NanoEnTek Inc., DeNovix Inc., Nexcelom Bioscience LLC (Revvity, Inc.), Merck KGaA, Sartorius AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Automated Cell Counter with Viability Analysis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brightfield Imaging
Fluorescence Imaging
Dual-Mode Imaging
Market segment by Sample Format
Slide-Based
Disposable Chamber-Based
Microfluidic Chip-Based
Market segment by Cell Concentration Range
Below 5×10⁶ cells/mL
5×10⁶–5×10⁷ cells/mL
Above 5×10⁷ cells/mL
Market segment by Application
Cell Therapy
Biopharmaceutical Manufacturing
Research Laboratories
Other
Major players covered
Thermo Fisher Scientific Inc.
Beckman Coulter Life Sciences
Bio-Rad Laboratories, Inc.
Logos Biosystems, Inc.
ChemoMetec A/S
NanoEnTek Inc.
DeNovix Inc.
Nexcelom Bioscience LLC (Revvity, Inc.)
Merck KGaA
Sartorius AG
Eppendorf SE
ALIT Life Science Co., Ltd.
Hangzhou Allsheng Instruments Co., Ltd.
Hangzhou Bioer Technology Co., Ltd.
Ningbo Scientz Biotechnology Co., Ltd.
Shanghai Ruiyu Biotechnology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Automated Cell Counter with Viability Analysis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Automated Cell Counter with Viability Analysis, with price, sales quantity, revenue, and global market share of Automated Cell Counter with Viability Analysis from 2021 to 2026.
Chapter 3, the Automated Cell Counter with Viability Analysis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Automated Cell Counter with Viability Analysis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Automated Cell Counter with Viability Analysis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Automated Cell Counter with Viability Analysis.
Chapter 14 and 15, to describe Automated Cell Counter with Viability Analysis sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Automated Cell Counter with Viability Analysis. Industry analysis & Market Report on Automated Cell Counter with Viability Analysis is a syndicated market report, published as Global Automated Cell Counter with Viability Analysis Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Automated Cell Counter with Viability Analysis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.